Skip to main content

Want a detailed portfolio tracker?

Olema Pharmaceuticals (OLMA) P/E (2020 - 2026)

Olema Pharmaceuticals (OLMA) P/E from Dec 31, 2020 to Jun 3, 2026. The TTM Olema Pharmaceuticals (OLMA) P/E is -4.33. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Olema Pharmaceuticals (OLMA)

YearP/EChange
2026-4.33-60.79%
2025-11.04+305.37%
2024-2.72-56.66%
2023-6.29+544.11%
2022-0.98-81.28%
2021-5.21-97.20%
2020-186.57N/A

Comparison Olema Pharmaceuticals (OLMA) P/E with competitors

Olema Pharmaceuticals (OLMA) P/E is -4.33.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.04%
NBYStablecoin Development Corp0.10-102.36%
ENLVEnlivex Therapeutics Ltd0.15-103.47%
FGENFibroGen Inc0.24-105.54%
TRAWTraws Pharma Inc0.47-110.92%
FBIOFortress Biotech Inc0.71-116.30%
CHRSCoherus Biosciences Inc0.98-122.58%
ORMPOramed Pharmaceuticals Inc1.47-134.02%
AGENAgenus Inc2.05-147.30%
VIVSVivoSim Labs Inc2.54-158.55%
INVAInnoviva Inc3.19-173.62%
CRMDCorMedix Inc3.65-184.18%
ABEOAbeona Therapeutics Inc4.20-197.09%
VXRTVaxart Inc4.26-198.40%
CVACCureVac N.V.4.45-202.65%
SRPTSarepta Therapeutics Inc4.62-206.77%
GLPGGalapagos NV4.86-212.19%
RIGLRigel Pharmaceuticals4.92-213.59%
ZVRAZevra Therapeutics Inc4.97-214.85%
ABUSArbutus Biopharma Corp5.69-231.47%
CGENCompugen Ltd7.38-270.50%
AUPHAurinia Pharmaceuticals Inc9.25-313.62%
ACADAcadia Pharmaceuticals Inc9.59-321.39%
OMEROmeros Corporation9.88-328.21%
PLXProtalix BioTherapeutics Inc9.91-328.81%
SPROSpero Therapeutics Inc10.73-347.87%
ADMAAdma Biologics Inc11.33-361.63%
SVASinovac Biotech Ltd11.44-364.06%
TBPHTheravance Biopharma Inc11.78-371.93%
HRMYHarmony Biosciences Holdings Inc12.18-381.25%
TGTXTG Therapeutics Inc13.18-404.32%
INCYIncyte Corp13.38-409.00%
SABSSAB Biotherapeutics Inc14.06-424.60%
XOMAXOMA Corp14.95-445.09%
REGNRegeneron Pharmaceuticals Inc14.98-445.90%
PBYIPuma Biotechnology Inc15.05-447.52%
EXELExelixis Inc15.79-464.71%
NAGENiagen Bioscience Inc16.35-477.64%
CPRXCatalyst Pharmaceuticals Inc17.34-500.50%
MDXGMimedx Group Inc17.38-501.20%
ARGXArgen X SE23.07-632.73%
HALOHalozyme Therapeutics Inc23.20-635.71%
XOMAOXOMA Corp25.34-685.22%
VRTXVertex Pharmaceuticals Inc25.66-692.40%
XOMAPXOMA Corp25.67-692.73%
CTMXCytomX Therapeutics Inc25.70-693.38%
ASNDAscendis Pharma A/S26.35-708.53%
RPRXRoyalty Pharma plc - Class A27.50-734.88%
SLNOSoleno Therapeutics Inc29.02-769.98%
LGNDLigand Pharmaceuticals Inc - Class B30.19-797.02%
BMRNBiomarin Pharmaceutical Inc37.51-966.06%
APLSApellis Pharmaceuticals Inc39.02-1001.02%
KRYSKrystal Biotech Inc39.70-1016.64%
GMABGenmab40.20-1028.32%
ONCBeiGene Ltd67.03-1647.69%
TECHBio-Techne Corp68.59-1683.89%
VCELVericel Corp80.63-1961.77%
PHARPharming Group N.V.87.74-2125.96%
ALNYAlnylam Pharmaceuticals Inc124.93-2984.78%
TLXTelix Pharmaceuticals Ltd139.89-3330.15%
CORTCorcept Therapeutics Inc158.39-3757.29%